logo
What this grieving daughter found online is helping thousands in Australia

What this grieving daughter found online is helping thousands in Australia

SBS Australiaa day ago
This article contains references to death. In a cosy apartment in Sydney, Vibha Gulati looks sadly at an old photograph, a cherished memory of her late mother, Bhusan. "She was an amazing person. She was very compassionate, very loving," Gulati said as she recalls people turned to her mother for advice, drawn by her wisdom and natural warmth. Both migrants from India, Gulati and her mother lived together in the city's west for 35 years, proud of their close bond. "We were like sisters and we shared each other's thoughts and feelings. We could actually tune into each other on the same wavelength," she said.
But their strength was tested when her mother was diagnosed with ovarian cancer, and doctors said she had just six months to live.
(Left to right) Prabha Gulati with her mother, Bhusan, and sister, Vibha. Source: Supplied / Vibha Gulati "It was shocking, really shocking. I was losing my best friend! We loved each other very much and she's greatly missed," Gulati said.
From loss to healing After losing her mother to cancer, Gulati turned to The Violet Initiative — a not-for-profit organisation, providing information and support to people in Australia to navigate the last stages of life and the grief that accompanies it. "The [counselling] guide [at Violet] helped me to navigate the grief I was feeling," Gulati said. "The loss was so great and it came in waves. Often, I thought I was alright and then suddenly I would be crying.
"I felt the guide really understood and held the space [for me] and did not negate any feelings that I had."
Vibha Gulati used the Violet counselling service after she lost her mother to cancer. Source: SBS / Spencer Austad Gulati is not alone. In recent years, almost 30,000 people have utilised Violet and its national network of guides, along with a digital support service. Violet CEO Melissa Reader said: "People come to us saying, 'I just do not know where to start'." "A common theme is: 'My mum is in her late eighties, and dad died a couple of years ago. I'm the eldest daughter stepping into a caregiving role. I'm managing my own family and a career and I'm completely overwhelmed'," she said.
"So [we] try to help families and communities be more prepared around the last stages of a person's life."
Violet CEO Melissa Reader said the initiative aims to start conversations around end-of-life planning. Source: SBS / Spencer Austad As Australia's population ages, services like Violet are becoming increasingly crucial. More than 180,000 Australians die each year, yet many leave behind no will or clear instructions about their end-of-life choices — forcing families to navigate both grief and complex legal processes. "Up to 90 per cent of us want to be cared for at home for as long as possible with our family and our friends and everything that's familiar to us, and the right services and supports. But that is not what's playing out today," Reader said. "We see people having at least four hospital admissions through the last 12 months, around 33 or 34 days, and we see one in two Australians dying in hospital. That is our least preferred place to die."
A large number of public hospital beds are occupied by patients who are predominantly elderly and in their final year of life, according to a 2024 report by The Violet Initiative. It states caring for dying people in hospitals costs around $4 billion annually.
Reader said that figure is forecast to rise. "We have about 12,000 people turning 85 each year today. In five years, that is forecast to increase fivefold to 60,000 people. And our health and age care systems are already at capacity," she said. Reader's husband Mauro died of cancer aged just 39, leaving her to raise their three children alone. She understands how hard it can be to face critical care decisions. "We were completely unprepared for Mauro's death. He died in intensive care and it was a very clinical and impersonal experience and quite frightening for all of us, including him," she said. "I really needed help to know how to bring him into a conversation [about his illness] in a way that was okay that he could manage.
"Then, we could have done so much more together in the last six months of his life, with far fewer regrets for all of us."
Melissa Reader (centre) with her late husband, Mauro, and their daughter, Mya. Source: Supplied / Melissa Reader Turning pain into purpose Reader said her husband's sudden death — and the lack of preparedness to deal with the emotional aftermath — inspired her to expand services to ease burdens for others facing a similar situation. In 2020, Reader relaunched an existing platform as Violet, a not-for-profit and social enterprise. The online resource aims to help more people navigate the end-of-life journey. "Violet is the last colour of the day and the first colour of the dawn. So it's a really lovely reference to the passing of time," she explained. "I don't think we can pretend to wave a magic wand and say everybody will have a death at home and it's going to be incredibly easy. This is not an easy stage of life. It's very complex, it's very emotional and there's a lot of uncertainty. "However, we would like to help people stay in their homes for longer with the right services and support and help families prepare, if their loved one wants to die at home."
For those seeking support, Violet offers an initial free consultation, and services are then available via subscription.
Mitch Gibson offers personal counselling at Violet. Source: SBS / Spencer Austad Mitch Gibson is among Violet's 50 guides and is proud to provide personal care and support to grieving families. Like most Violet volunteers, she has struggled to cope with personal loss. "I was trying to run my own small business, a yoga studio, and then my dad was diagnosed with dementia and my life partner, Mark, was diagnosed with stage four pancreatic cancer," she said. "And to say that my world flipped upside down is an understatement."
That was 11 years ago, but for Gibson the memories remain vivid and the eventual loss of her partner led to a life-changing decision.
Mitch Gibson with her late partner Mark, who died of pancreatic cancer. Source: Supplied / Mitch Gibson "I was only 56 years old, and I decided I wanted to work as a grief and bereavement counsellor and care for carers. As I had lived experience, Violet was an ideal choice," Gibson said. "These are the conversations I want to be having. This is the help I want to be offering. I didn't ask for this to happen to me, but it did. "I am someone who has cared [for a dying person], and someone who has grieved. So why not use that to help someone else?" Violet also offers an AI-enabled digital companion that provides personalised support in multiple languages to people in need. Yaniv Bernstein, Violet's chief product and technology officer, said: "What we have is a really clever, voice-based artificial intelligence agent that talks to people in the manner of a normal conversation."
"People can have a conversation at any time, in many languages of their choice. And what they then get is a real assessment of where they're at, what stage they're in, what their needs are," Bernstein said.
'This has to change' Violet chair Kate Carnell warns Australia is facing a looming crisis in how it handles death and dying. She said the country is dangerously unprepared — emotionally, socially and economically — for the realities of end-of-life care. "We are sleepwalking into this century's biggest economic and social crisis. Research indicates that eight to 11 per cent of Australia's total health budget is spent on people in their final stage of life," she said. "As well, only 14 per cent of Australians have a plan in place for the end of life. This has to change!
"Digital technology plays an important role in making services and information available to all Australians when they need it 24/7. And that's what Violet is providing."
A portrait of Vibha Gulati's mother, Bhusan, as a young woman. Source: Supplied / Vibha Gulati Gulati and her mother were among the few who carefully planned for the end of life. After her diagnosis, Bhusan refused medical treatment and chose voluntary assisted dying (VAD) at home in the care of her daughters, Prabha and Vibha. "It was important for her. She opted for VAD because she wanted control over her death and the whole process of her illness," Gulati said. "She did not want any chemotherapy or radiation. Surgery was an option, but that was also refused. "She managed herself quite well. She was ill during the final week and could not lift herself up from the bed. But until the week she passed away, my mother was going out to cafes and restaurants." Gulati said faith — a mix of Buddhist, Hindu and spiritual beliefs — helped the family respectfully bid farewell to her mother in December last year. "We had chanting here while she was passing away. We did Indian mantras infused with spiritual energy," she said.
"It helped her to transition more smoothly and it also created a very calming effect on the mind and on the emotions. So, it works for the people involved and the person who's passing away too."
Vibha Gulati is still learning to cope with grief after losing her mother. Source: SBS / Spencer Austad While faith has helped Gulati navigate grief, she said the loss remains painful and hard to bear. "I can feel her presence around me sometimes. So, it's really, really lovely. But that loss is still there and it takes a long time to adjust to," she said. "However, my spiritual belief gives me strength and gives me trust that I will meet her again and that she has not gone forever." Support is available through LifeLine on 13 11 14 or Griefline which provides confidential support on 1300 845 745 and via griefline.org.au
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Second case of rare mpox strain discovered in traveller
Second case of rare mpox strain discovered in traveller

SBS Australia

time3 hours ago

  • SBS Australia

Second case of rare mpox strain discovered in traveller

Listen to Australian and world news, and follow trending topics with SBS News Podcasts . "The patient has a close family, and that family are isolating at home. He was not contagious on the return journey to Australia from Africa, and those close contacts that he has been in contact including at the emergency ward and other locations are being contact traced right now and identified." That's Queensland's Health Minister Tim Nicholls, confirming a new strain of mpox virus has been detected in a man who's just returned to the south-east of the state from a trip to Africa. He says Mpox is a disease caused by the monkeypox virus. "Mpox is not easily spread. It is only spread or it can only spread through close or intimate contact. It is particularly spread by close sexual contact and particularly for gay men and people engaging with sex is the primary cause of the contagious spread." Dr Geoffrey Playford is the head of infectious diseases at the Princess Alexandra Hospital in Queensland. He says the rare Clade 1 strain of mpox has only been seen once before in Australia, also in a returned traveller. "Over the last year and a half in Queensland, we've had 135 cases in mpox clade 2 - this is the first case of clade 1 and the second time in Australia we've had clade 1. The other case was in New South Wales in May." Mr Nicholls says the public should NOT be concerned. "We think that there are 19 community contacts and 40 staff contacts that have been in contact with the patient. At the moment his symptoms are asymptomatic. They are not showing any signs of the clade 1 mpox, but they are isolating. The family involves children in high school, primary school and childcare centres and the high school, primary school and childcare centres either have been or are in the process of being identified." Dr Playford says authorities are not worried either. He says fortunately in this case the clinical presentation is relatively mild and there are no particular concerns for the patient's health. "And all of our efforts at the moment is to identify contacts using national guidelines to undertake quarantine where the very close contacts have been identified, again in line with the national guidelines." The close contacts will be offered a vaccine that is highly effective against mpox -either preventing or making the disease significantly milder and shorter. Mr Nicholls says over a year ago there were some restrictions on the availability of the vaccine. But now, Queensland has ample supplies - and the vaccine is provided free of charge through sexual health clinics and some GPs [[general practitioners]]. The Queensland government is advising anyone who suspects they may have the virus to seek medical advice from their local doctor, sexual health clinic or public health unit.

How some Aussies are tackling the 'massive hurdles' of ADHD diagnosis and treatment
How some Aussies are tackling the 'massive hurdles' of ADHD diagnosis and treatment

SBS Australia

time6 hours ago

  • SBS Australia

How some Aussies are tackling the 'massive hurdles' of ADHD diagnosis and treatment

When Zac Altman returned to Australia, he didn't expect that a frustrating journey trying to get rediagnosed with ADHD would propel him to start a business seeking to address the flaws of the system. Altman is the founder of Kantoko, a telehealth platform that offers ADHD assessment and care under a subscription model. After being diagnosed with ADHD while living in the United States, he returned home — and found he needed to start his diagnosis journey from scratch. "I was already diagnosed, already on the medication, had the documentation. I thought it was going to be pretty straightforward. And for me, it was a challenge," he told SBS News. "I don't think I ever would've made it through the process if I were starting in Australia from the get-go because of the massive hurdles and burdens required with getting through the process." Altman's struggles reflect a broader issue when it comes to the diagnosis and treatment of ADHD in Australia: despite rising awareness and demand, the system is still playing catch-up — and some states are lagging behind. Zac Altman says he would never have founded his ADHD telehealth business if he hadn't struggled with the diagnosis process himself. Source: Supplied A postcode lottery All states and territories have different laws governing how stimulant medications — commonly prescribed to treat ADHD — can be prescribed and dispensed. In some places, the process is more streamlined. In others, patients face stricter regulatory barriers — often accompanied by longer wait times and higher costs. Dr Roger Paterson, a psychiatrist based in Western Australia, said there was "always a postcode privilege for all levels of healthcare". "ADHD treatment is no different," he told SBS News. He said ADHD diagnosis and treatment rates have surged in Australia — but not uniformly. "We're still below the prevalence rates … but some states and territories have caught up quicker than others." Paterson told SBS News. Patterson said South Australia, Tasmania, Victoria and the Northern Territory remain the slowest to catch up, while Western Australia — which once lagged behind — has now reached similar levels to Queensland. "No-one really knows why [some states lag], beyond the NT not having many specialists — paediatricians or psychiatrists. But they are all gradually catching up to the ADHD prevalence rates." Prevalence refers to the proportion of a population that is affected by ADHD. While there are no Australian adult prevalence studies of ADHD using the current DSM-5 diagnostic criteria, some studies have indicated the prevalence of ADHD in Australia is likely to be similar to that found internationally — between 2 and 6 per cent of the population, according to the Australasian ADHD Professionals Association. Rates of prescribing vary across states and territories, reflecting the different jurisdictional laws about stimulant prescribing. Source: SBS News Additionally, the federal government's Drug Utilisation Sub Committee September 2023 report found differences in the rates of prescribing across states and territories, which the report says reflects different laws across jurisdictions. Adult rates of prescribing were significantly higher in Western Australia and the ACT compared to the other states and the Northern Territory. The federal Senate inquiry into ADHD, handed down in November 2023, examined the barriers to consistent, timely and best-practice assessment of ADHD. It heard those living in regional and rural areas were subject to even more barriers to care, with reduced access to specialists, longer wait times and higher costs. Altman said the differences were most pronounced in Kantoko clients moving interstate who had to navigate different jurisdictional regulations, sometimes requiring them to find an entirely new specialist. "It seems somewhat unreasonable to expect every psychiatrist to know every quirk across the country ... which is why I would argue we should have some sort of national standard around this stuff," he said. A patchwork system with no national rules Altman said going through the assessment process in Australia can feel like "a roll of the dice" due to a lack of national rules. He said he paid about $1,500 out of pocket to be rediagnosed in his first year back in Australia — including an upfront $1,000 fee to secure a psychiatrist appointment in NSW. He said he was fortunate to have leftover medication from the US to tide him over in the months he waited, but he knows others aren't so lucky. "It's the luck of the draw," he said. The inquiry heard that of those who did have positive experiences of ADHD assessment and diagnosis, "many attributed their experience to luck" or to doctors and psychiatrists who helped them access services. There is no national framework for ADHD, despite it being a key recommendation in the inquiry. The inquiry heard wait times were found to be "significant", typically between six and 18 months for an initial appointment, while the Australian Association of Psychologists Inc said the number of mental health professionals has not kept up with the demand for services. The public system rarely treats the condition except in children, pushing adults seeking a diagnosis to the private sector. As specialists set their own fees with no cap, people can be subject to high fees. The ADHD Foundation said it had observed some professionals charge up to $5,000 for assessments. 'Kantoko wouldn't exist if Australia nailed it' In response, ADHD telehealth services like Kantoko have cropped up. Operating completely online, these clinics promise shorter wait times — but sometimes at a greater cost. Kantoko operates under a subscription model. Medicare does not cover any fees. In exchange, patients are promised an ADHD assessment by a qualified psychiatrist, follow-up appointments with mental health doctors and prescription renewals. "Kantoko wouldn't exist if Australia had nailed it," Altman said. "I wouldn't have gotten so frustrated that I started this business and embarked on this journey if it were easy-to-access and affordable." But the Senate inquiry heard concerns about the growing telehealth service model, saying that while it was helpful for those in regional areas, it has also driven up risks associated with "inadequate assessment and misdiagnosis", according to the Australian College of Mental Health Nurses. The Canberra and Queanbeyan ADHD Support Group, a volunteer-run local group, said the clinics offered "exceedingly high fees delivering a quick turnaround" with concerns of "price gouging". The GP debate: solving shortages or lowering the bar? As the system plays catch-up, a key recommendation from the inquiry was the development of uniform and nationally consistent ADHD prescribing rules — the only recommendation of the 15 that the government accepted in full. But the government said the establishment of prescribing arrangements, including increased GP involvement, was a matter for state and territory governments. NSW, ACT, SA and WA have committed to reforms that will allow specially trained GPs to prescribe ADHD medication independently from 2025 and 2026. They'll join jurisdictions like Queensland, where GPs have been able to prescribe certain ADHD medications for children without prior approval since 2017. While some say it could ease bottlenecks and encourage holistic care, others warn it risks lowering the standards of care. Paterson said the current model is for specialists to handle diagnosis and stabilisation, before shifting to a shared care arrangement with GPs — known as co-prescribing. He's sceptical of political moves to shift ADHD treatment onto GPs in an effort to play catch-up. "Some GPs have pushed for taking on initial, independent assessment and prescribing, and politicians push this along as a popular way of reducing waiting lists," Paterson said. "This creates a tension between reducing waitlists with more GP involvement on the one hand, but on the other hand, accepting that GP ADHD management may not have the nuance of specialist management." There are concerns that relaxing GP restrictions could open the door to so-called 'dexy clinics' — where stimulant medications such as dexamphetamines might be handed out too freely, similar to concerns seen with medicinal cannabis. "There would be less concern about lower GP numbers who are highly trained, and more concern about higher GP numbers who are less trained," Paterson said. "The worst case scenario is that stimulant medication becomes as accessible as cannabis from the medicinal cannabis clinics." But Dr Alison Poulton, a senior lecturer in paediatrics at The University of Sydney and member of ADHD Australia's advisory board, pushed back against 'dexy clinic' fears, saying that ongoing relationships between GPs and patients would reduce risk and encourage more holistic care. She criticised current restrictions requiring specialist endorsement and fixed dosage limits, arguing they undermine both patient autonomy and the ability of GPs to tailor care. "It makes complete nonsense of patient autonomy," she said. "Decisions should be made between the GP and patient, not based on a letter written five years ago." Poulton emphasised that GPs, who often have a long-term understanding of their patients, are well placed to make prescribing decisions that reflect changing needs, leading to better functional outcomes. "I think the GPs are going to do a much better job if they know it's up to them to make these prescribing decisions rather than to have to consult the specialist."

Aussie supplement company Blackmores facing potential class action over allegedly ‘toxic' levels of B6 in products
Aussie supplement company Blackmores facing potential class action over allegedly ‘toxic' levels of B6 in products

News.com.au

time6 hours ago

  • News.com.au

Aussie supplement company Blackmores facing potential class action over allegedly ‘toxic' levels of B6 in products

Australian supplement giant Blackmores is facing potential class-action lawsuit, over claims that excessive levels of vitamin B6 in some of the company's over-the-counter products have led to serious health complications. Dominic Noonan-O'Keeffe began taking Blackmores supplements in May 2023 to support his health, ahead of the birth of his first child. Unaware the magnesium product contained potentially 'toxic' levels of vitamin B6, he claims he soon developed severe symptoms – including fatigue, headaches, muscle spasms, heart palpitations, and loss of sensation, according to Polaris lawyers. Doctors later diagnosed him with neuropathy linked to excessive B6 intake. Despite stopping in early 2024, Mr Noonan-O'Keeffe claims he continues to suffer daily from nerve pain and other symptoms. Polaris Lawyers – who are representing Mr Noonan-O'Keeffe, the lead plaintiff in the potential class-action – allege they later discovered the magnesium product contained about 29 times the recommended daily intake of vitamin B6. Polaris Lawyers is now investigating a proposed class action against Blackmores for the excessive B6 levels in their vitamin supplements. 'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake,' Polaris Lawyers Founder and Principal Nick Mann said. 'What happened to Dominic is tragic, but he is not alone – we are aware of reports that excessive levels of B6 in over-the-counter supplements may have caused lasting injuries to hundreds of Australians. 'Polaris Lawyers is currently investigating a class action on behalf of anyone who has suffered injuries as a result of excessive levels of B6 as a result of taking Blackmores vitamin supplements.' In an interim decision report released in June, the TGA acknowledged no clear consensus on a safe vitamin B6 level that fully prevents peripheral neuropathy. The decision proposed rescheduling products containing over 50mg per day as 'Pharmacist Only Medicines.' A Blackmores spokesperson said they were aware of the TGA's proposed changes. 'At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' the spokesperson said. 'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements. 'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store